ROLE OF RED BLOOD CELLS IN PHARMACOKINETICS OF CHEMOTHERAPEUTIC AGENTS
作者： Dirk Schrijvers , Ernst De Bruyn , Allan T Van Oosterom , Jan B Vermorken
DOI: 10.1097/00001813-199902000-00002
关键词: Pharmacology 、 Metabolism 、 Plasma water 、 Blood proteins 、 Chemistry 、 Pharmacokinetics
摘要: After oral or parenteral administration of chemotherapeutic agents, these drugs are transported to the tissues by blood in different fractions: plasma water, proteins cells. Erythrocytes may play an important role storage, transport and metabolism agents.
springer.com
sci-hub.se 参考文章(46)
Frank M. Balis, John S. Holcenberg, David G. Poplack, Jeffrey Ge, Harland N. Sather, Robert F. Murphy, Matthew M. Ames, Mary J. Waskerwitz, David G. Tubergen, Solomon Zimm, Gerald S. Gilchrist, W. Archie Bleyer, Pharmacokinetics and Pharmacodynamics of Oral Methotrexate and Mercaptopurine in Children With Lower Risk Acute Lymphoblastic Leukemia: A Joint Children’s Cancer Group and Pediatric Oncology Branch Study Blood. ,vol. 92, pp. 3569- 3577 ,(1998) , 10.1182/BLOOD.V92.10.3569
Martin S. Highley, Ernst A. De Bruijn, Erythrocytes and the transport of drugs and endogenous compounds. Pharmaceutical Research. ,vol. 13, pp. 186- 195 ,(1996) , 10.1023/A:1016074627293
Paul S. Gaynon, Bruce Bostrom, Gary Erdmann, Cellular pharmacology of 6-mercaptopurine in acute lymphoblastic leukemia Journal of Pediatric Hematology Oncology. ,vol. 15, pp. 80- 86 ,(1993) , 10.1097/00043426-199302000-00010
J.B. Vermorken, W.J.F. van der Vijgh, I. Klein, H.E. Gall, A.A.M. Hart, H.M. Pinedo, Pharmacokinetics of free and total platinum species after short-term infusion of cisplatin. Cancer treatment reports. ,vol. 68, pp. 505- 513 ,(1984)
Pendyala L, Creaven Pj, In vitro cytotoxicity, protein binding, red blood cell partitioning, and biotransformation of oxaliplatin. Cancer Research. ,vol. 53, pp. 5970- 5976 ,(1993)
E Cvitkovic, M Boisdron-Celle, J Robert, E Gamelin, F Larra, A Krikorian, A Turcant, A L Bouil, R Delva, S Brienza, A Cailleux, P Allain, Cumulative pharmacokinetic study of oxaliplatin, administered every three weeks, combined with 5-fluorouracil in colorectal cancer patients. Clinical Cancer Research. ,vol. 3, pp. 891- 899 ,(1997)
J.B. Vermorken, F. Elferink, W.J.F. van der Vijgh, H.E. Gall, I. Klein, H.M. Pinedo, Pharmacokinetics of diammine(l,l cyclobutanedi carboxylato) platinum(II) (carboplatin) after intravenous administration Cancer treatment reports. ,vol. 71, pp. 1231- 1237 ,(1987)
T. Walle, G. N. Kumar, U. K. Walle, Kapil Bhalla, Binding of taxol to human plasma, albumin and alpha 1-acid glycoprotein. Research communications in chemical pathology and pharmacology. ,vol. 80, pp. 337- 344 ,(1993)
Pierre Allain, Anne Le Bouil, Erik Gamelin, Annie Cailleux, Oliver Heudi, Michele Boisdron-Celle, Francis Larra, Early biotransformations of oxaliplatin after its intravenous administration to cancer patients. Drug Metabolism and Disposition. ,vol. 28, pp. 1379- 1384 ,(2000)
Allen Krantz, Red Cell-Mediated Therapy: Opportunities and Challenges Blood Cells Molecules and Diseases. ,vol. 23, pp. 58- 68 ,(1997) , 10.1006/BCMD.1997.0119